Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
Clinical trial NCT06085729 · RECRUITING
Trial details
- NCT number
- NCT06085729
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-29
- Primary completion
- 2027-09-02
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.